Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.

Chk2/hcds1, the human homolog of the Saccharomyces cerevisiae RAD53/SPK1 and Schizosaccharomyces pombe cds1 DNA damage checkpoint genes, encodes a protein kinase that is post-translationally modified after DNA damage. Like its yeast homologs, the Chk2/hCds1 protein phosphorylates Cdc25C in vitro, suggesting that it arrests cells in G(2) in response to DNA damage. We expressed Chk2/hCds1 in human cells and analyzed their cell cycle profile. Wild-type, but not catalytically inactive, Chk2/hCds1 led to G(1) arrest after DNA damage. The arrest was inhibited by cotransfection of a dominant-negative p53 mutant, indicating that Chk2/hCds1 acted upstream of p53. In vitro, Chk2/hCds1 phosphorylated p53 on Ser-20 and dissociated preformed complexes of p53 with Mdm2, a protein that targets p53 for degradation. In vivo, ectopic expression of wild-type Chk2/hCds1 led to increased p53 stabilization after DNA damage, whereas expression of a dominant-negative Chk2/hCds1 mutant abrogated both phosphorylation of p53 on Ser-20 and p53 stabilization. Thus, in response to DNA damage, Chk2/hCds1 stabilizes the p53 tumor suppressor protein leading to cell cycle arrest in G(1).

[1]  M. Fritsche,et al.  Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. , 1993, Oncogene.

[2]  A. Levine,et al.  Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.

[3]  C. Purdie,et al.  Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.

[4]  P. Russell,et al.  Replication checkpoint enforced by kinases Cds1 and Chk1. , 1998, Science.

[5]  T. Hupp,et al.  DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site , 1998, Oncogene.

[6]  M. Laiho,et al.  p53 transactivation and protein accumulation are independently regulated by UV light in different phases of the cell cycle , 1997, Molecular and cellular biology.

[7]  D. Lane,et al.  p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding , 1997, Oncogene.

[8]  N. Walworth,et al.  S-phase-specific activation of Cds1 kinase defines a subpathway of the checkpoint response in Schizosaccharomyces pombe. , 1998, Genes & development.

[9]  M. Kastan,et al.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Koshland,et al.  The anaphase inhibitor of Saccharomyces cerevisiae Pds1p is a target of the DNA damage checkpoint pathway. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Alexander Wlodawer,et al.  The structural basis for spectral variations in green fluorescent protein , 1997, Nature Structural Biology.

[12]  A. Carr,et al.  The Schizosaccharomyces pombe rad3 checkpoint gene. , 1996, The EMBO journal.

[13]  P. Russell,et al.  Basis for the Checkpoint Signal Specificity That Regulates Chk1 and Cds1 Protein Kinases , 1999, Molecular and Cellular Biology.

[14]  A. Levine,et al.  Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Wahl,et al.  A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. , 1996, Genes & development.

[16]  T. Halazonetis,et al.  Many faces of ATM: eighth international workshop on ataxia-telangiectasia. , 1999, Biochimica et biophysica acta.

[17]  E. Lane,et al.  An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. , 1999, Experimental cell research.

[18]  K. Sakaguchi,et al.  DNA damage activates p53 through a phosphorylation-acetylation cascade. , 1998, Genes & development.

[19]  T. Weinert DNA Damage and Checkpoint Pathways Molecular Anatomy and Interactions with Repair , 1998, Cell.

[20]  P. Herrlich,et al.  DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation , 1999, Oncogene.

[21]  A. Levine,et al.  A functionally inactive p53 protein interatocarcinoma cells is activated by either DNA damage or cellular differentiation , 1996, Nature Medicine.

[22]  Y Taya,et al.  Enhanced phosphorylation of p53 by ATM in response to DNA damage. , 1998, Science.

[23]  K. Khanna,et al.  Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. , 1993, Oncogene.

[24]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[25]  K. Isselbacher,et al.  Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. , 1999, Science.

[26]  Y Taya,et al.  DNA damage‐inducible phosphorylation of p53 at N‐terminal sites including a novel site, Ser20, requires tetramerization , 1999, The EMBO journal.

[27]  H. Wang,et al.  Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms. , 1999, Science.

[28]  W. Maltzman,et al.  UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells , 1984, Molecular and cellular biology.

[29]  S. Elledge,et al.  RAD9 and DNA polymerase epsilon form parallel sensory branches for transducing the DNA damage checkpoint signal in Saccharomyces cerevisiae. , 1996, Genes & development.

[30]  M. Nakanishi,et al.  Role of Human Cds1 (Chk2) Kinase in DNA Damage Checkpoint and Its Regulation by p53* , 1999, The Journal of Biological Chemistry.

[31]  T. Halazonetis,et al.  Identification of an additional negative regulatory region for p53 sequence-specific DNA binding. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Elledge,et al.  Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. , 1998, Science.

[33]  T. Unger,et al.  Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2 , 1999, The EMBO journal.

[34]  Stephen N. Jones,et al.  Regulation of p53 stability by Mdm2 , 1997, Nature.

[35]  R. Bernards,et al.  rad-Dependent Response of the chk1-Encoded Protein Kinase at the DNA Damage Checkpoint , 1996, Science.

[36]  A. Blasina,et al.  A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase , 1999, Current Biology.

[37]  S. Berger,et al.  p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage , 1999, Molecular and Cellular Biology.

[38]  H. Piwnica-Worms,et al.  A human Cds 1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage , 1999 .

[39]  A. Levine p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[40]  G. Stark,et al.  The p53 activation and apoptosis induced by DNA damage are reversibly inhibited by salicylate , 1997, Oncogene.

[41]  M. Kapoor,et al.  Functional activation of p53 via phosphorylation following DNA damage by UV but not γ radiation , 1998 .

[42]  L. Breeden,et al.  Rad53-dependent phosphorylation of Swi6 and down-regulation of CLN1 and CLN2 transcription occur in response to DNA damage in Saccharomyces cerevisiae. , 1997, Genes & development.

[43]  A. Fornace,et al.  The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. , 1994, Cancer research.

[44]  Y Taya,et al.  Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.

[45]  J. Little,et al.  Loss of normal G1 checkpoint control is an early step in carcinogenesis, independent of p53 status. , 1999, Cancer research.

[46]  Y Taya,et al.  The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. , 2000, Genes & development.

[47]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[48]  S. Moreno,et al.  Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1 , 1998, Nature.

[49]  M. Kapoor,et al.  Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Levine,et al.  Nucleo‐cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein , 1998, The EMBO journal.

[51]  N. Rhind,et al.  Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. , 1997, Science.

[52]  Stephen J. Elledge,et al.  Cell Cycle Checkpoints: Preventing an Identity Crisis , 1996, Science.

[53]  J. Little,et al.  Absence of a radiation-induced first-cycle G1-S arrest in p53+ human tumor cells synchronized by mitotic selection. , 1998, Cancer research.

[54]  G. Stark,et al.  A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[55]  T. Tlsty,et al.  Separate pathways for p53 induction by ionizing radiation and N-(phosphonoacetyl)-L-aspartate. , 1996, Cancer research.

[56]  Y Taya,et al.  DNA damage induces phosphorylation of the amino terminus of p53. , 1997, Genes & development.

[57]  U. Knippschild,et al.  p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs , 1997, Oncogene.

[58]  E. Stavridi,et al.  Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions , 1999, Protein science : a publication of the Protein Society.

[59]  Xin Lu,et al.  Differential induction of transcriptionally active p53 following UV or lonizing radiation: Defects in chromosome instability syndromes? , 1993, Cell.

[60]  Yoichi Taya,et al.  ATM associates with and phosphorylates p53: mapping the region of interaction , 1999, Nature Genetics.

[61]  H. Piwnica-Worms,et al.  A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[62]  D. Stern,et al.  Spk1/Rad53 is regulated by Mec1-dependent protein phosphorylation in DNA replication and damage checkpoint pathways. , 1996, Genes & development.

[63]  S. Elledge,et al.  Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. , 1997, Science.

[64]  Y Taya,et al.  A role for ATR in the DNA damage-induced phosphorylation of p53. , 1999, Genes & development.

[65]  E. Stavridi,et al.  Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[66]  S. Schreiber,et al.  cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[67]  T. Halazonetis,et al.  Structure–based rescue of common tumor–derived p53 mutants , 1996, Nature Medicine.

[68]  A. Levine,et al.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.

[69]  C. Westphal,et al.  Atm-dependent interactions of a mammalian Chk1 homolog with meiotic chromosomes , 1997, Current Biology.

[70]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[71]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[72]  M. Kubbutat,et al.  Regulation of p53 Function and Stability by Phosphorylation , 1999, Molecular and Cellular Biology.

[73]  M. T. Brewer,et al.  Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist , 1990, Nature.

[74]  Scott W. Lowe,et al.  p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.

[75]  B. Stillman,et al.  Cdc7p–Dbf4p kinase binds to chromatin during S phase and is regulated by both the APC and the RAD53 checkpoint pathway , 1999, The EMBO journal.

[76]  M. Lovett,et al.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.

[77]  E. Stavridi,et al.  ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins , 1998, Nature Genetics.

[78]  S. Elledge,et al.  Regulation of RAD53 by the ATM-Like Kinases MEC1 and TEL1 in Yeast Cell Cycle Checkpoint Pathways , 1996, Science.

[79]  J. Little,et al.  Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines. , 1995, Oncogene.